Therefore, controlling the expression, transcriptional activity and subcellular location of TFE3 might be three key points to control the progression of Xp11.2 tRCC. Here, TFE3 is linked to renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.